首页> 外文OA文献 >Automated telephone communication systems for preventive healthcare and management of long-term conditions
【2h】

Automated telephone communication systems for preventive healthcare and management of long-term conditions

机译:用于预防性医疗保健和长期病症管理的自动电话通信系统

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundudAutomated telephone communication systems (ATCS) can deliver voice messages and collect health-related information from patientsudusing either their telephone’s touch-tone keypad or voice recognition software. ATCS can supplement or replace telephone contactudbetween health professionals and patients. There are four different types of ATCS: unidirectional (one-way, non-interactive voiceudcommunication), interactive voice response (IVR) systems, ATCS with additional functions such as access to an expert to request adviceud(ATCS Plus) and multimodal ATCS, where the calls are delivered as part of a multicomponent intervention.udObjectivesudTo assess the effects of ATCS for preventing disease and managing long-term conditions on behavioural change, clinical, process,udcognitive, patient-centred and adverse outcomes.udSearch methodsudWe searched 10 electronic databases (the Cochrane Central Register of Controlled Trials; MEDLINE; Embase; PsycINFO; CINAHL;udGlobal Health; WHOLIS; LILACS; Web of Science; and ASSIA); three grey literature sources (Dissertation Abstracts, Index to Theses,udAustralasian Digital Theses); and two trial registries (www.controlled-trials.com; www.clinicaltrials.gov) for papers published betweenud1980 and June 2015.udSelection criteriaudRandomised, cluster- and quasi-randomised trials, interrupted time series and controlled before-and-after studies comparing ATCSudinterventions, with any control or another ATCS type were eligible for inclusion. Studies in all settings, for all consumers/carers, in anyudpreventive healthcare or long term condition management role were eligible.udData collection and analysisudWe used standard Cochrane methods to select and extract data and to appraise eligible studies.udMain resultsudWe included 132 trials (N = 4,669,689). Studies spanned across several clinical areas, assessing many comparisons based on evaluationudof different ATCS types and variable comparison groups. Forty-one studies evaluated ATCS for delivering preventive healthcare, 84 forudmanaging long-term conditions, and seven studies for appointment reminders. We downgraded our certainty in the evidence primarilyudbecause of the risk of bias for many outcomes. We judged the risk of bias arising from allocation processes to be low for just over halfudthe studies and unclear for the remainder. We considered most studies to be at unclear risk of performance or detection bias due toudblinding, while only 16% of studies were at low risk. We generally judged the risk of bias due to missing data and selective outcomeudreporting to be unclear.udFor preventive healthcare, ATCS (ATCS Plus, IVR, unidirectional) probably increase immunisation uptake in children (risk ratio (RR)ud1.25, 95% confidence interval (CI) 1.18 to 1.32; 5 studies, N = 10,454; moderate certainty) and to a lesser extent in adolescents (RRud1.06, 95% CI 1.02 to 1.11; 2 studies, N = 5725; moderate certainty). The effects of ATCS in adults are unclear (RR 2.18, 95% CIud0.53 to 9.02; 2 studies, N = 1743; very low certainty).udFor screening, multimodal ATCS increase uptake of screening for breast cancer (RR 2.17, 95% CI 1.55 to 3.04; 2 studies, N = 462;udhigh certainty) and colorectal cancer (CRC) (RR 2.19, 95% CI 1.88 to 2.55; 3 studies, N = 1013; high certainty) versus usual care.udIt may also increase osteoporosis screening. ATCS Plus interventions probably slightly increase cervical cancer screening (moderateudcertainty), but effects on osteoporosis screening are uncertain. IVR systems probably increase CRC screening at 6 months (RR 1.36,ud95% CI 1.25 to 1.48; 2 studies, N = 16,915; moderate certainty) but not at 9 to 12 months, with probably little or no effect of IVRud(RR 1.05, 95% CI 0.99, 1.11; 2 studies, 2599 participants; moderate certainty) or unidirectional ATCS on breast cancer screening.udAppointment reminders delivered through IVR or unidirectional ATCS may improve attendance rates compared with no calls (lowudcertainty). For long-term management, medication or laboratory test adherence provided the most general evidence across conditionsud(25 studies, data not combined). Multimodal ATCS versus usual care showed conflicting effects (positive and uncertain) on medicationudadherence. ATCS Plus probably slightly (versus control; moderate certainty) or probably (versus usual care; moderate certainty) improvesudmedication adherence but may have little effect on adherence to tests (versus control). IVR probably slightly improves medicationudadherence versus control (moderate certainty). Compared with usual care, IVR probably improves test adherence and slightly increasesudmedication adherence up to six months but has little or no effect at longer time points (moderate certainty). Unidirectional ATCS,udcompared with control, may have little effect or slightly improve medication adherence (low certainty). The evidence suggested little orudno consistent effect of any ATCS type on clinical outcomes (blood pressure control, blood lipids, asthma control, therapeutic coverage)udrelated to adherence, but only a small number of studies contributed clinical outcome data.udThe above results focus on areas with the most general findings across conditions. In condition-specific areas, the effects of ATCSudvaried, including by the type of ATCS intervention in use.udMultimodal ATCS probably decrease both cancer pain and chronic pain as well as depression (moderate certainty), but other ATCSudtypes were less effective. Depending on the type of intervention, ATCS may have small effects on outcomes for physical activity,udweight management, alcohol consumption, and diabetes mellitus. ATCS have little or no effect on outcomes related to heart failure,udhypertension, mental health or smoking cessation, and there is insufficient evidence to determine their effects for preventing alcohol/udsubstance misuse or managing illicit drug addiction, asthma, chronic obstructive pulmonary disease, HIV/AIDS, hypercholesterolaemia,udobstructive sleep apnoea, spinal cord dysfunction or psychological stress in carers.udOnly four trials (3%) reported adverse events, and it was unclear whether these were related to the interventions
机译:背景 ud自动电话通信系统(ATCS)可以使用电话的按键式小键盘或语音识别软件向患者传递语音消息并收集与健康相关的信息。 ATCS可以补充或替代卫生专业人员与患者之间的电话联系。 ATCS有四种不同类型:单向(单向,非交互式语音 udcommunication),交互式语音响应(IVR)系统,具有其他功能的ATCS,例如可以访问专家以请求建议 ud(ATCS Plus)和 udObjectives ud评估ATCS预防疾病和管理长期状况对行为改变,临床,过程,认知,以患者为中心和不良后果的影响 ud搜索方法 ud我们搜索了10个电子数据库(Cochrane对照试验中央注册; MEDLINE; Embase; PsycINFO; CINAHL; udGlobal Health; WHOLIS; LILACS; Web of Science和ASSIA);三个灰色文献来源(论文摘要,论文索引, udAustralasian数字论文); ud1980年至2015年6月之间发表的论文有两个试验注册中心(www.control-trials.com; www.clinicaltrials.gov)。以及随后进行的将ATCS udintervention与任何对照或其他ATCS类型进行比较的研究均符合纳入条件。 ud预防性医疗保健或长期病情管理角色中所有消费者/护理者在所有情况下的研究均符合条件。 ud数据收集和分析 ud我们使用标准的Cochrane方法来选择和提取数据并评估合格的研究。 ud主要结果 ud我们纳入了132个试验(N = 4,669,689)。研究跨越多个临床领域,基于对不同ATCS类型和可变比较组的评估 ud,评估了许多比较。有41项研究评估了ATCS用于提供预防性保健的能力,有84项评估了对长期病情的控制,还有7项评估了约会提醒的研究。我们主要是由于存在许多结果存在偏见的风险,因此降低了证据的确定性。我们认为,分配过程引起的偏见风险在一半以上的研究中较低,而在其余研究中尚不清楚。我们认为大多数研究由于“盲目性”而导致性能或检测偏倚的风险尚不清楚,而只有16%的研究处于低风险。我们通常判断由于缺少数据和选择性结局而导致偏倚的风险不清楚。 ud对于预防保健,ATCS(ATCS Plus,IVR,单向)可能会增加儿童的免疫吸收(风险比(RR) ud1.25) ,95%置信区间(CI)为1.18至1.32; 5个研究,N = 10,454;中度确定性),而在青少年中则较小(RR ud1.06,95%CI为1.02至1.11; 2个研究,N = 5725;中等确定性)。目前尚不清楚ATCS在成人中的作用(RR 2.18,95%CI ud0.53至9.02; 2个研究,N = 1743;非常低的确定性)。 ud对于筛查,多模式ATCS可提高乳腺癌筛查的吸收率(RR 2.17) ,95%CI为1.55至3.04; 2项研究,N = 462;具有极高的确定性)和结直肠癌(CRC)(RR 2.19,95%CI为1.88至2.55; 3项研究,N = 1013;高确定性)。它也可能增加骨质疏松症的筛查。 ATCS Plus干预措施可能会略微增加子宫颈癌的筛查(中等/不确定性),但对骨质疏松症筛查的影响尚不确定。 IVR系统可能会在6个月时增加CRC筛查(RR 1.36, ud95%CI 1.25至1.48; 2个研究,N = 16,915;中度确定性),但在9到12个月时没有,对IVR ud的影响很小甚至没有。 RR 1.05,95%CI 0.99,1.11; 2个研究,2599名参与者;中度确定性)或单向ATCS在乳腺癌筛查中。对于长期管理,药物或实验室检查的依从性提供了跨状况的最一般证据 ud(25个研究,未合并数据)。多模式ATCS与常规护理相比,对药物依从性的影响(正面和不确定)相互矛盾。 ATCS Plus可能稍微(相对于对照;中等确定性)或可能(相对于常规护理;中度确定性)改善对药物的依从性,但对依从性的影响很小(相对于对照)。与对照相比,IVR可能会稍微改善药物治疗/依从性(中等确定性)。与常规护理相比,IVR可能会改善测试依从性,并在长达六个月的时间内略微提高药物治疗依从性,但在更长的时间点上几乎没有影响(没有确定性)。单向ATCS,与控制相比,可能影响很小或对药物依从性有轻微改善(确定性较低)。证据表明,任何ATCS类型对依从性的临床结局(血压控制,血脂,哮喘控制,治疗覆盖率)几乎没有或没有一致的影响,但只有少数研究提供了临床结局数据。结果集中在跨条件发现最普遍的领域。在特定条件的地区,ATCS的影响会有所不同,包括所用ATCS干预的类型。ud多模式ATCS可能会减轻癌症疼痛和慢性疼痛以及抑郁症(中度确定性),但其他ATCS的影响却较小有效。根据干预的类型,ATCS可能对体育锻炼,减重管理,饮酒和糖尿病的结局影响很小。 ATCS对与心力衰竭,高血压,精神健康或戒烟有关的结局影响很小或没有影响,并且没有足够的证据来确定其对预防酒精/物质滥用或管理非法药物成瘾,哮喘,慢性阻塞性肺疾病的影响,艾滋病毒/艾滋病,高胆固醇血症,非阻塞性​​睡眠呼吸暂停,脊髓功能障碍或护理人员的心理压力。 ud只有四项试验(3%)报告了不良事件,目前尚不清楚这些不良事件是否与干预措施有关

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号